CSB 2.009 Note
(km) Tiletamine and Zolazepam or any salt thereof;
CSB 2.009 Note
(7) Paragraph (a) of s. 161.16 (3), Stats., is renumbered to read:
CSB 2.009 Note
(am) Alphaprodine;
CSB 2.009 Note
(8) Paragraph (a) of s.
161.16 (3), Stats., is created to read:
CSB 2.009 Note
(a) Alfentanil;
CSB 2.009 Note
(9) Paragraph (rg) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(rg) MPPP 1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.009 Note
(10) Paragraph (vg) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(vg) (PEPAP) 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;
CSB 2.009 Note
(11) Paragraph (b) of s.
161.16 (10), Stats., is created to read:
CSB 2.009 Note
(b) Nabilone (another name for nabilone: (+)-trans-3- (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1- hydroxy-6, 6-dimethyl-9H-dibenzo [b,d] pyran-9-one).
CSB 2.009 Note
(12) Subsection
(2) of s.
161.14, Stats., is amended to read:
CSB 2.009 Note
(2) Opiates. Unless specifically excepted under federal regulations or unless listed in another schedule, any of the following opiates, or their isomers, esters, ethers, salts, salts of isomers, esters of ethers, if isomers, esters, ethers, salts or salts of isomers exist within the specified chemical designation (for purposes of par. (tg) only, the term isomer includes the optical and geometric isomers):
CSB 2.009 Note
(13) Paragraph (a) of s. 161.14 (2), Stats., is renumbered to read:
CSB 2.009 Note
(ag) Acetylmethadol;
CSB 2.009 Note
(14) Paragraph (a) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(a) Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.009 Note
(15) Paragraph (cg) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(cg) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(16) Paragraph (dg) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl) -4-piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(17) Paragraph (rj) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(rj) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(18) Paragraph (tg) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(tg) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1- (2-phenethyl)-4-piperidinyl]propanamide);
CSB 2.009 Note
(19) Paragraph (xm) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(xm) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);
CSB 2.009 History
History:
Cr.
Register, February, 1988, No. 386, eff. 3-1-88.
CSB 2.009 Note
CSB 2.20 Addition of beta-hydroxy-3-methylfentanyl to schedule I. Paragraph (er) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(er) Beta-hydroxy-3-methylfentanyl.
CSB 2.009 History
History:
Cr.
Register, July, 1989, No. 403, eff. 8-1-89.
CSB 2.009 Note
CSB 2.21 Additions, deletions, corrections, transfers, and amendments to drug schedules. (1) Subsection
(1) of s.
161.14, Stats., is amended to read:
CSB 2.009 Note
(1) Included substances. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I.
CSB 2.009 Note
(2) Paragraph (a) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(a) Acetyl-alpha-methylfentany (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.009 Note
(3) Paragraph (er) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(er) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2- phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(4) Paragraph (rg) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.009 Note
(5) Paragraph (qs) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(qs) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(6) Paragraph (tg) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);
CSB 2.009 Note
(7) Paragraph (vg) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
CSB 2.009 Note
(8) Paragraph (xm) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(xm) Thiofentanyl (N-[1-(2-thienyl)ethyl-4-piperidinyl]-N-
phenylpropanamide);
CSB 2.009 Note
(9) Paragraph (cd) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(cd) Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(10) Paragraph (e) of s.
161.14 (3), Stats., is amended to read:
CSB 2.009 Note
(e) Codeine-N-oxide;
CSB 2.009 Note
(11) Paragraph (j) of s.
161.14 (3), Stats., is amended to read:
CSB 2.009 Note
(j) Etorphine, except its hydrochloride salts;
CSB 2.009 Note
(12) Paragraph (s) of s.
161.14 (3), Stats., is amended to read:
CSB 2.009 Note
(s) Morphine-N-oxide;
CSB 2.009 Note
(13) Paragraph (a) of s.
161.14 (4), Stats., is amended to read:
CSB 2.009 Note
(a) 3,4-methylenedioxyamphetamine, commonly known as “MDA";
CSB 2.009 Note
(14) Paragraph (b) of s.
161.14 (4), Stats., is amended to read:
CSB 2.009 Note
(b) 5-methoxy-3,4-methylenedioxyamphetamine;
CSB 2.009 Note
(15) Paragraph (c) of s.
161.14 (4), Stats., is amended to read:
CSB 2.009 Note
(c) 3,4,5-trimethoxyamphetamine;
CSB 2.009 Note
(16) Paragraph (ag) of s.
161.14 (4), Stats., is created to read:
CSB 2.009 Note
(ag) 3,4-methylenedioxyethylamphetamine, commonly known as “MDE";
CSB 2.009 Note
(17) Paragraph (ar) of s.
161.14 (4), Stats., is created to read:
CSB 2.009 Note
(ar) N-hydroxy-3,4-methylenedioxyamphetamine;
CSB 2.009 Note
(18) Paragraph (u) of s.
161.14 (4), Stats., is amended to read:
CSB 2.009 Note
(u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
CSB 2.009 Note
(19) Paragraph (ud) of s.
161.14 (4), Stats., is created to read:
CSB 2.009 Note
(ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
CSB 2.009 Note
(20) Paragraph (ur) of s.
161.14 (4), Stats., is amended to read:
CSB 2.009 Note
(ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
CSB 2.009 Note
(21) Paragraph (d) of s.
161.14 (7), Stats., is created to read:
CSB 2.009 Note
(d) 4-methylaminorex, including its salts and salts of isomers;
CSB 2.009 Note
(22) Paragraph (e) of s.
161.14 (7), Stats., is created to read:
CSB 2.009 Note
(e) N,N-dimethylamphetamine, including its salts and salts of isomers.
CSB 2.009 Note
(23) Paragraph (L) of s.
161.14 (7), Stats., is created to read:
CSB 2.009 Note
(L) methcathinone, including its salts and salts of isomers.
CSB 2.009 Note
(24) Subdivision 4m of s.
161.16 (2) (a), Stats., is created to read:
CSB 2.009 Note
4m. Dihydrocodeine;
CSB 2.009 Note
(25) Paragraph (d) of s. 161.16 (3), Stats., is repealed.
CSB 2.009 Note
(26) Paragraph (am) of s.
161.16 (7), Stats., is created to read:
CSB 2.009 Note
(am) Glutethimide;
CSB 2.009 Note
(27) Subsection (9) of s. 161.16, Stats., is repealed.
CSB 2.009 Note
(28) Subsection
(20m) of s.
161.01, Stats., is created to read:
CSB 2.009 Note
(20m) (a) “Anabolic steroid" means any drug or hormonal substance, chemically or pharmacologically related to testosterone (except estrogens, progestin, and corticosteroids), that promotes muscle growth. The term includes all of the substances listed in s. 161.18 (7), and their esters, isomers, esters of isomers, salts and salts of esters, isomers and esters of isomers, that are theoretically possible under the specific chemical designation, and if such esters, isomers, esters of isomers, salts and salts of esters, isomers and esters of isomers promote muscle growth.
CSB 2.009 Note
(b) Except as provided in par. (c), the term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the United States secretary of health and human services for such administration.
CSB 2.009 Note
(c) If a person prescribes, dispenses or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of par. (a).
CSB 2.009 Note
(29) Subsection
(7) of s.
161.18, Stats., is created to read:
CSB 2.009 Note
(7) Anabolic steroids. Any material, compound, mixture, or preparation containing any quantity of the following anabolic steroids, including any of their esters, isomers, esters of isomers, salts and salts of esters, isomers and esters of isomers, whenever those esters, isomers, esters of isomers, salts and salts [of] esters, isomers and esters of isomers exist within the specific chemical designation:
